Anne Philomena Hyland
Corporate Officer/Principal bei London Stock Exchange Plc
Vermögen: 39 112 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Anne Philomena Hyland
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Chemicals: Specialty | 27 | |
| Subsidiary | Pharmaceuticals: Major | 14 | |
London Stock Exchange Plc
 London Stock Exchange Plc Investment Banks/BrokersFinance London Stock Exchange Plc, operates as a stock exchange. It offers capital market, trading, information, derivatives, studio, regulatory, enhanced, connectivity, telephone network, reference and historical data, historic price, corporate action, trade data, valuation data, broker ranking, matching and reconciliation. The company was founded in 1571 and is headquartered in London, the United Kingdom.
14
| Subsidiary | Investment Banks/Brokers | 14 |
| Subsidiary | Miscellaneous Commercial Services | 13 | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.
8
| Holding Company | Pharmaceuticals: Major | 8 |
| Public Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anne Philomena Hyland
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Chief Operating Officer Director/Board Member Director/Board Member Director/Board Member | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Founder Chairman Chairman Chief Executive Officer | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| BTG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chairman | |
| LONDON STOCK EXCHANGE PLC | Internet Software/Services | Corporate Secretary Director/Board Member Director/Board Member | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| UBS | Investment Managers | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Executive Officer | |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| BENEVOLENTAI | Biotechnology | Chairman Director/Board Member Director of Finance/CFO | |
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Chairman Director/Board Member Director of Finance/CFO | |
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| LOW & BONAR PLC | Textiles | Director/Board Member Chief Executive Officer Chief Executive Officer | |
| The University of Edinburgh | College/University | Doctorate Degree Graduate Degree | |
Summit (Cambridge) Ltd.
 Summit (Cambridge) Ltd. Pharmaceuticals: MajorHealth Technology Summit (Cambridge) Ltd. develops and manufactures drugs and pharmaceuticals. It discovers and develops therapeutics for neurological, ophthalmologic, metabolic, and gastrointestinal diseases. The company was founded in 2001 by Paul Goldsmith and Mark Carlton and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director of Finance/CFO Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Chairman Director/Board Member | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder | |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| Queen Mary University of London | College/University | Undergraduate Degree Graduate Degree | |
| ELECTRICAL GEODESICS INC | Medical Specialties | Director of Finance/CFO Director/Board Member | |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member | |
BioCity Group Ltd
 BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Director of Finance/CFO | |
| OPTOS PLC | Medical Specialties | Chairman Director of Finance/CFO | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| E-THERAPEUTICS PLC | Biotechnology | Director/Board Member Director of Finance/CFO | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree | |
| ARECOR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| The University of Sheffield | College/University | Undergraduate Degree Undergraduate Degree | |
| NUFORMIX PLC | Biotechnology | Chairman Director/Board Member | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Idis Ltd.
 Idis Ltd. Drugstore ChainsRetail Trade Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom | Drugstore Chains | Director/Board Member Director/Board Member | |
| University of Bristol | College/University | Undergraduate Degree Doctorate Degree | |
| LONZA GROUP AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
South East Water Ltd.
 South East Water Ltd. Water UtilitiesUtilities South East Water Ltd. supplies drinking water. It takes water from rivers, reservoirs and underground sources under abstraction licenses issued by the environment agency. The firm supplies water in Kent, Sussex, Surrey, Hampshire and Berkshire. The company was founded in 1992 and is headquartered in Snodland, the United Kingdom. | Water Utilities | Director/Board Member Chairman | |
Celltech Group Ltd.
 Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 37 |
| Schweiz | 5 |
| Deutschland | 4 |
| Vereinigte Staaten | 4 |
| Frankreich | 3 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 5 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 556 |
| Independent Dir/Board Member | 165 |
| Corporate Officer/Principal | 164 |
| Chairman | 156 |
| Chief Executive Officer | 67 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Kevin Boyd | 66 |
| Annalisa Jenkins | 51 |
| Andrew Richards | 44 |
| John Brown | 36 |
| Susan Foden | 32 |
| Elmar Schnee | 31 |
| Alf Gunnar Martin Nicklasson | 31 |
| Catherine Moukheibir | 29 |
| Ian Johnson | 29 |
| Peter Allen | 27 |
| Nick Salmon Salmon | 27 |
| David Chiswell | 23 |
| Jean-Michel Cossery | 21 |
| Peter John Fellner | 21 |
| Simon Sturge | 20 |
- Börse
- Insiders
- Anne Philomena Hyland
- Unternehmensverbindungen
